Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-Hydroxytamoxifen

Evans, 1988, The steroid and thyroid hormone receptor superfamily., Science, 240, 889, 10.1126/science.3283939

Tsai, 1994, Molecular mechanisms of action of steroid/thyroid receptor superfamily members., Annu Rev Biochem, 63, 451, 10.1146/annurev.bi.63.070194.002315

Beekman, 1993, Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain., Mol Endocrinol, 7, 1266

Tsai, 1988, Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation., Cell, 55, 361, 10.1016/0092-8674(88)90059-1

Kumar, 1988, The estrogen receptor binds tightly to its response element as a ligand-induced homodimer., Cell, 55, 145, 10.1016/0092-8674(88)90017-7

Tora, 1989, The human estrogen receptor has two independent nonacidic transcriptional activation functions., Cell, 59, 477, 10.1016/0092-8674(89)90031-7

Lees, 1989, Identification of two transactivation domain in the mouse oestrogen receptor., Nucleic Acids Res, 17, 5477, 10.1093/nar/17.14.5477

Tzukerman, 1994, Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions., Mol Endocrinol, 8, 21

Pham, 1992, Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast., Mol Endocrinol, 6, 1043

Wakeling, 1990, Novel pure antiestrogens: mode of action and therapeutic prospects., Ann NY Acad Sci, 595, 348, 10.1111/j.1749-6632.1990.tb34308.x

Wakeling, 1991, A potent specific pure antiestrogen with clinical potential., Cancer Res, 51, 3867

Katzenellenbogen, 1996, Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones., Mol Endocrinol, 10, 119

Webster, 1988, The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function., Cell, 54, 199, 10.1016/0092-8674(88)90552-1

Berry, 1990, Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen., EMBO J, 9, 2811, 10.1002/j.1460-2075.1990.tb07469.x

Osborne, 1991, Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen., J Natl Cancer Inst, 83, 1477, 10.1093/jnci/83.20.1477

Gottardis, 1989, Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens., Cancer Res, 49, 4090

Gottardis, 1988, Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse., Cancer Res, 48, 812

Horwitz, 1996, Nuclear receptor coactivators and corepressors., Mol Endocrinol, 10, 1167

Shibata, 1997, Role of coactivators and corepressors in the mechanism of steroid/thyroid receptor action., Recent Prog Horm Res

Ogryzko, 1996, The transcriptional coactivators p300 and CBP are histone acetyltransferases., Cell, 87, 953, 10.1016/S0092-8674(00)82001-2

Halachmi, 1994, Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription., Science, 264, 1455, 10.1126/science.8197458

Oñate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily., Science, 270, 1354, 10.1126/science.270.5240.1354

Chen, 1995, A transcriptional co-repressor that interacts with nuclear hormone receptors., Nature, 377, 454, 10.1038/377454a0

Norris, 1996, Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity., Mol Endocrinol, 10, 1605, 10.1210/mend.10.12.8961270

Webb, 1995, Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens., Mol Endocrinol, 9, 443

Vik, 1991, Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence., Biochemistry, 30, 1080, 10.1021/bi00218a029

Juan, 1993, Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3., Proc Natl Acad Sci USA, 90, 2584, 10.1073/pnas.90.7.2584

Danielian, 1992, Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors., EMBO J, 11, 1025, 10.1002/j.1460-2075.1992.tb05141.x

Smith, 1993, Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone., Proc Natl Acad Sci USA, 90, 6120, 10.1073/pnas.90.13.6120

Power, 1991, Dopaminergic and ligand-independent activation of steroid hormone receptors., Science, 254, 1636, 10.1126/science.1749936

Aronica, 1993, Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1., Mol Endocrinol, 7, 743

Fujimoto, 1994, Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectively and promoter dependence., Mol Endocrinol, 8, 296

McDonnell, 1995, Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens., Mol Endocrinol, 9, 659

McInerney, 1996, Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator., Proc Natl Acad Sci USA, 93, 10069, 10.1073/pnas.93.19.10069

Takeshita, 1996, Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator., Endocrinology, 137, 3594, 10.1210/endo.137.8.8754792

Smith, 1995, Oestrogen receptor activation in the absence of ligand., Biochem Soc Trans, 23, 935, 10.1042/bst0230935

Kamei, 1996, A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors., Cell, 85, 403, 10.1016/S0092-8674(00)81118-6

Lundblad, 1995, Adenoviral EIA-associated protein p300 as a functional homologue of the transcriptional co-activator CBP., Nature, 374, 85, 10.1038/374085a0

Janknecht, 1996, MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP., Biochem Biophys Res Commun, 228, 831, 10.1006/bbrc.1996.1740

Bannister, 1995, Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro., Oncogene, 11, 2509

Dai, 1996, CBP as a transcriptional coactivator of c-Myb., Genes Dev, 10, 528, 10.1101/gad.10.5.528

Bannister, 1995, CBP-induced stimulation of c-Fos activity is abrogated by EIA., EMBO J, 14, 4758, 10.1002/j.1460-2075.1995.tb00157.x

Kurokawa, 1995, Polarity-specific activities of retinoic acid receptors determined by a co-repressor., Nature, 377, 451, 10.1038/377451a0

Sande, 1996, Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors., Mol Endocrinol, 10, 813

Zamir, 1996, A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains., Mol Cell Biol, 16, 5458, 10.1128/MCB.16.10.5458

Downes, 1996, Transcriptional repression by Rev-erbAα is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR., Nucleic Acids Res, 24, 3490, 10.1093/nar/24.18.3490

Shibata, Gene silencing by COU P-TFI is mediated by transcriptional corepressors N-CoR and SMRT., Mol Endocrinol

Smith, 1993, Steroid receptors and their associated proteins., Mol Endocrinol, 7, 4

Reese, 1992, Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens., Mol Cell Biol, 12, 4531, 10.1128/MCB.12.10.4531

Lee, 1996, Hormone-dependent transactivation by estrogen receptor chimeras that do not interact with hsp90., J Biol Chem, 271, 25727, 10.1074/jbc.271.42.25727

Xu, 1996, The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor., Proc Natl Acad Sci USA, 93, 12195, 10.1073/pnas.93.22.12195

Cavailles, 1995, Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor., EMBO J, 14, 3741, 10.1002/j.1460-2075.1995.tb00044.x

Yao, 1996, The nuclear hormone receptor coactivator SRC-1 is a specific target of p300., Proc Natl Acad Sci USA, 93, 10626, 10.1073/pnas.93.20.10626

Voegel, 1996, TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors., EMBO J, 15, 3667, 10.1002/j.1460-2075.1996.tb00736.x

Chen, 1996, SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers., Proc Natl Acad Sci USA, 93, 7567, 10.1073/pnas.93.15.7567

Hörlein, 1995, Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor., Nature, 377, 397, 10.1038/377397a0

Santen, 1996, Editorial: Long term tamoxifen therapy: can an antagonist become an agonist?, J Clin Endocrinol Metab, 81, 2027, 10.1210/jcem.81.6.8964823

Fisher, 1994, Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14., J Natl Cancer Inst, 86, 527, 10.1093/jnci/86.7.527

Allan, 1992, Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation., J Biol Chem, 267, 19513, 10.1016/S0021-9258(18)41805-4

Baniahmad, 1995, Enhancement of human estrogen receptor activity by SPT6: a potential coactivator., Mol Endocrinol, 9, 34